Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Lando Biomaterials has developed several advanced biomedical materials including an absorbable collagen membrane that has completed a randomized controlled clinical trial demonstrating efficacy in oral bone repair. The company also manufactures innovative hydrogels with antibacterial properties for wound healing. Its collaborative work includes a UK-China partnership developing a novel osteochondral scaffold now progressing to human trials. Products such as artificial skin are already used clinically in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Lando Biomaterials.